Lai H. Wei
Elite in Hepatitis C

Lai H. Wei

Hepatology
No. 168, Litang Road, 
Changping, CN 
Elite in Hepatitis C
No. 168, Litang Road, 
Changping, CN 
OverviewLocationsClinical Research

Overview

Lai Wei is a Hepatologist in Changping, China. Mr. Wei is rated as an Elite expert by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, Hepatitis B, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

His clinical research consists of co-authoring 574 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 148 articles and participated in 1 clinical trial in the study of Hepatitis C.

Specialties
Hepatology
Gender
Male

Locations

No. 168, Litang Road, Changping, China
Other Locations
No.168, Litang Road, Changping, 102218, China
No. 168, Litang Road, Changping, 102218, China
Pr, Tianjin, 300192, China
Xinjiekouwai Street, Beijing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Open-label, Dose-ranging, Phase II Study to Evaluate the Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in Treatment naïve Subjects With Chronic Hepatic C Virus Genotype I Infection
A Multicenter, Randomized, Open-label, Dose-ranging, Phase II Study to Evaluate the Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in Treatment naïve Subjects With Chronic Hepatic C Virus Genotype I Infection
Enrollment Status: Completed
Publish Date: February 18, 2021
Intervention Type: Drug
Study Phase: Phase 2

572 Total Publications

Analysis of the efficacy of orlistat combined with pioglitazone and metformin in the treatment of obese patients with type 2 diabetes mellitus
Analysis of the efficacy of orlistat combined with pioglitazone and metformin in the treatment of obese patients with type 2 diabetes mellitus
Journal: Zhonghua yi xue za zhi
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wei's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile